Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies', we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies', only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Mirae Harford, former NIHR Academic Clinical Fellow at OUCAGS, writes about her experiences and how funders can help break down barriers to women’s success in academia.

Dr Harford’s NIHR blog, ‘Smashing stereotypes: The quest to improve gender equality for female early career researchers’, was written on Women’s Day 2022. It highlights the challenges faced by early-careers researchers juggling career and family responsibilities. It also reviews some of the support available and suggests additional steps to support early-career female researchers.

Similar stories

Multiple heart-related conditions linked to dementia risk, finds OUCAGS alumnus

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk. This is according to findings from a large-scale new study co-led by the University of Oxford and published by OUCAGS alumnus Dr Xin You Tai and colleagues.

Oxford MedSci Goes Silver: 10 Years of Athena Swan

Celebrating a gender equality milestone in Oxford's Medical Sciences Division: all departments have achieved an Athena Swan silver award

COVID-19: Clinical academic trainees joined the front-line effort en masse

The BMJ has highlighted the contribution of clinical academic trainees to clinical duties during the pandemic. It has emphasised how they brought clinical and research expertise to the Covid effort – in many cases to the detriment of their academic work and career.

COVID-19 survivors at risk of psychiatric illness, finds OUCAGS ACF

Dr Maxime Taquet, Academic Clinical Fellow (ACF), and colleagues have found ‘evidence for substantial neurological and psychiatric morbidity in the 6 months after COVID-19 infection’.